Mucopolysaccharidosis Type II
7 clinical trials · Condition
◉ Watch Mucopolysaccharidosis Type II
| Record | Firm | Date |
|---|---|---|
| A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II (NCT05208281) | AO GENERIUM | 2021-11-30 |
| Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II (NCT06022380) | Manchester University NHS Foundation Trust | 2020-09-28 |
| A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers (NCT04539340) | AO GENERIUM | 2020-02-28 |
| Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III (NCT03161171) | University Hospital Heidelberg | 2017-07-06 |
| Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI (NCT02437253) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2015-05-01 |
| Longitudinal Studies of Brain Structure and Function in MPS Disorders (NCT01870375) | University of Minnesota | 2009-09-01 |
Track Mucopolysaccharidosis Type II automatically
Every clearance here is in the API, with alerts when new ones post.